CELG Income Statement

Click line-items for a historical chart and %
Revenue:
Net product sales 1.43B
Collaborative agreements and other revenue 7.1M
Royalty revenue 28.2M
Total revenue 1.46B
Expenses:
Cost of goods sold (excluding amortization of acquired intangible assets)
Research and development 452.4M
Selling, general and administrative 369M
Amortization of acquired intangible assets 65.7M
Acquisition related (gains) charges and restructuring, net 33.2M
Total costs and expenses 1B
Operating income 463.8M
Other income and expense:
Interest and investment income, net 4.8M
Equity in (gains) losses of affiliated companies
Interest expense -17.9M
Other income, net -2.3M
Income before income taxes 448.4M
Income tax provision 63.5M
Net income 384.9M
Less: Net loss attributable to non-controlling interest
Net income attributable to Celgene
Net income per share attributable to Celgene:
Basic 0.92
Diluted 0.89
Weighted average shares:
Basic 417.9M
Diluted 432.2M

Entities mentioned with CELG

View All Entities